BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7153234)

  • 1. Extracorporeal circulation with perfluorochemicals (Fluosol-DA).
    Hoshino S; Iwaya F; Igari T; Kanno M; Honda K
    J Cardiovasc Surg (Torino); 1982; 23(6):463-9. PubMed ID: 7153234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Present status of clinical studies of Fluosol-DA (20%) in Japan.
    Mitsuno T; Ohyanagi H
    Int Anesthesiol Clin; 1985; 23(1):169-84. PubMed ID: 3980104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of blood and Fluosol-DA for cardiopulmonary bypass.
    Rousou JA; Engelman RM; Anisimowicz L; Dobbs WA
    J Cardiovasc Surg (Torino); 1985; 26(5):447-53. PubMed ID: 4030876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxygenation effect of fluosol-DA on hypoxic tumor tissue and retention of PFCs in the tumor-bearing rats.
    Watanabe M; Okamoto H; Ohyanaqi H; Saitoh Y; Yano K; Tsuda Y; Ueda Y; Yokoyama K
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):547-56. PubMed ID: 3140922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Fluosol-DA 20% and oxygen on response of C57BL/6 mice to whole-body irradiation.
    Waldow SM; Lustig RA; Brass-Marlow EL; Nunno MP; Holst RJ; Wallner PE
    Int J Radiat Oncol Biol Phys; 1990 Sep; 19(3):665-8. PubMed ID: 2211213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of fluosol-DA infusion on pulmonary vascular permeability in the dog lung.
    Hall JE; Ehrhart IC; Hofman WF
    J Trauma; 1986 May; 26(5):432-7. PubMed ID: 3084806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perfluorochemicals as US contrast agents for tumor imaging and hepatosplenography: preliminary clinical results.
    Mattrey RF; Strich G; Shelton RE; Gosink BB; Leopold GR; Lee T; Forsythe J
    Radiology; 1987 May; 163(2):339-43. PubMed ID: 3550878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a transfusion with a blood substitute (Fluosol-DA, 20%) on cerebral circulation in the monkey.
    Nagasawa S; Handa H; Naruo Y; Oda Y; Yonekawa Y; Takebe Y
    Neurol Res; 1981; 3(3):237-50. PubMed ID: 6122175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of Fluosol-DA in acute cerebral ischemia.
    Peerless SJ; Ishikawa R; Hunter IG; Peerless MJ
    Stroke; 1981; 12(5):558-63. PubMed ID: 6795765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Fluosol-DA and hetastarch on local cerebral blood flow, cortical O2 availability and computerized EEG data during cerebral ischaemia.
    Tranmer BI; Iacobacci R; Feiler S
    Neurol Res; 1990 Mar; 12(1):17-22. PubMed ID: 1692110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a perfluorocarbon emulsion (Fluosol-DA) on reticuloendothelial system clearance function.
    Castro O; Nesbitt AE; Lyles D
    Am J Hematol; 1984 Jan; 16(1):15-21. PubMed ID: 6695906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic and oxygen transport effects of a perfluorochemical blood substitute, fluosol-DA (20%).
    Tremper KK; Lapin R; Levine E; Friedman A; Shoemaker WC
    Crit Care Med; 1980 Dec; 8(12):738-41. PubMed ID: 7449405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approaches to defining the mechanism of enhancement by Fluosol-DA 20% with carbogen of melphalan antitumor activity.
    Teicher BA; Holden SA; Jacobs JL
    Cancer Res; 1987 Jan; 47(2):513-8. PubMed ID: 3098413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of hemodynamics and O2 transport associated with the perfluorochemical blood substitute, Fluosol-DA.
    Nishimura N; Sugi T
    Crit Care Med; 1984 Jan; 12(1):36-8. PubMed ID: 6690204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in RBC flux, acidosis and oxygenation in tumour microregions by Fluosol-DA 20%.
    Lee I; Cunningham WP; Levitt SH
    Int J Radiat Biol; 1991 Oct; 60(4):695-705. PubMed ID: 1680148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluosol DA and oxygen as an adjuvant to the radiotherapeutic management of advanced head/neck carcinoma.
    Lustig RA; Rose CM; McIntosh-Lowe NL
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):511-8. PubMed ID: 3179488
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experimental studies on the effect of perfluorochemicals in tumor irradiation].
    Shinoda J; Iwai T; Hattori T; Kondo H; Sakai N; Yamada H
    Gan No Rinsho; 1984 Jan; 30(1):53-8. PubMed ID: 6700116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased radiosensitivity of tumors by perfluorochemicals and carbogen.
    Song CW; Zhang WL; Pence DM; Lee I; Levitt SH
    Int J Radiat Oncol Biol Phys; 1985 Oct; 11(10):1833-6. PubMed ID: 3930442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluosol-DA: an artificial blood for total cardiopulmonary bypass.
    Engelman RM; Rousou JH; Dobbs WA
    Ann Thorac Surg; 1981 Dec; 32(6):528-35. PubMed ID: 7316587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short term survival following perfusion with fluosol-DA for cardiopulmonary bypass.
    Rousou JA; Engelman RM; Breyer RH; Allred C; Forouhar F
    Int J Artif Organs; 1985 Sep; 8(5):281-6. PubMed ID: 3936789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.